Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw
- PMID: 23264610
- DOI: 10.1177/0022034512472335
Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw
Abstract
Locally applied bisphosphonates may improve the fixation of metal implants in bone. However, systemic bisphosphonate treatment is associated with a risk of osteonecrosis of the jaw (ONJ). We hypothesized that local delivery of bisphosphonate from the implant surface improves the fixation of dental implants without complications in a setting where systemic treatment induces ONJ. Forty rats were randomly allocated to 4 groups of 10. All groups received a titanium implant inserted in an extraction socket. Group I received the implants only. Group II received dexamethasone (0.5 mg/kg). Group III received dexamethasone as above plus alendronate (200 µg/kg). Group IV received zoledronate-coated implants and dexamethasone as above. The animals were sacrificed 2 weeks after tooth extraction. All 10 animals with systemic alendronate treatment developed large ONJ-like changes, while all with local treatment were completely healed. Implant removal torque was higher for the bisphosphonate-coated implants compared with the other groups (p < 0.03 for each comparison). Micro-computed tomography of the maxilla showed more bone loss in the systemic alendronate group compared with groups receiving local treatment (p = 0.001). Local bisphosphonate treatment appears to improve implant fixation in a setting where systemic treatment caused ONJ.
Similar articles
-
Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.J Oral Pathol Med. 2012 Jul;41(6):494-9. doi: 10.1111/j.1600-0714.2011.01125.x. Epub 2012 Jan 23. J Oral Pathol Med. 2012. PMID: 22268631
-
Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model.Int J Oral Maxillofac Surg. 2013 May;42(5):632-6. doi: 10.1016/j.ijom.2013.02.007. Epub 2013 Mar 15. Int J Oral Maxillofac Surg. 2013. PMID: 23499148
-
Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study.J Oral Implantol. 2015 Jul;41 Spec No:360-5. doi: 10.1563/AAID-JOI-D-13-00063. Epub 2013 Sep 16. J Oral Implantol. 2015. PMID: 24041299
-
Efficacy of systemic bisphosphonate delivery on osseointegration of implants under osteoporotic conditions: lessons from animal studies.Arch Oral Biol. 2014 Sep;59(9):912-20. doi: 10.1016/j.archoralbio.2014.05.016. Epub 2014 May 16. Arch Oral Biol. 2014. PMID: 24908376 Review.
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
Cited by
-
Bisphosphonate-coated external fixation pins appear similar to hydroxyapatite-coated pins in the tibial metaphysis and to uncoated pins in the shaft.Acta Orthop. 2013 Jun;84(3):314-8. doi: 10.3109/17453674.2013.797315. Epub 2013 Apr 28. Acta Orthop. 2013. PMID: 23621808 Free PMC article. Clinical Trial.
-
Effects of local application of alendronate on early healing of extraction socket in dogs.Clin Oral Investig. 2020 Apr;24(4):1579-1589. doi: 10.1007/s00784-019-03031-7. Epub 2019 Jul 26. Clin Oral Investig. 2020. PMID: 31346723
-
Bisphosphonate releasing dental implant surface coatings and osseointegration: A systematic review.J Taibah Univ Med Sci. 2017 Jun 17;12(5):369-375. doi: 10.1016/j.jtumed.2017.05.007. eCollection 2017 Oct. J Taibah Univ Med Sci. 2017. PMID: 31435266 Free PMC article. Review.
-
Controlling drug delivery kinetics from mesoporous titania thin films by pore size and surface energy.Int J Nanomedicine. 2015 Jul 8;10:4425-36. doi: 10.2147/IJN.S83005. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26185444 Free PMC article.
-
Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.J Bone Miner Metab. 2020 Jul;38(4):581-588. doi: 10.1007/s00774-020-01089-y. Epub 2020 Feb 19. J Bone Miner Metab. 2020. PMID: 32076874
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
